AHA today Oct. 24 a Special Bulletin with updates from Baxter on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on its manufacturing facility in North Carolina. Baxter anticipates restarting the highest-throughput IV solutions manufacturing line at the impacted plant within the next week. In addition, the Food and Drug Administration authorized temporary importation for a variety of products from two additional Baxter plants in Thailand and Singapore, bringing the total number of facilities authorized to import products to seven. See AHA’s Special Bulletin for more updates.

Related News Articles

Headline
With numerous care locations across Florida, Lee Health has endured three major hurricanes over the past two years. In this conversation, Scott Nygaard, M.D.,…
Headline
The recent Hurricane Helene disrupted the production and supply of IV fluids due to the temporary closure of a Baxter manufacturing plant in North Carolina — a…
Headline
The Centers for Disease Control and Prevention has issued a health advisory on the supply disruption of peritoneal dialysis and intravenous solutions due to…
Headline
As part of its regular updates  on the IV solution supply disruption as a result of the temporary closure of a manufacturing plant in North Carolina,…
Headline
The Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, Oct. 10 activated the Emergency Prescription…
Perspective
When a natural disaster or emergency strikes, where is one of the first places people turn to? Their local hospital.That’s because hospitals and health systems…